Advanced breast cancer incidence following population-based mammographic screening

Annals of Oncology

Volumn 22, Issue 8, 2011, Pages 1726-1735

  Autier, P ^a   Boniol, M ^a   Middleton, R ^b   Dore J F ^c   Hery C ^c   Zheng, T ^d   Gavin, A ^b  

^a INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c INSERM   (France)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cancer registry; Incidence; Screening; Stage

Indexed keywords

AUSTRALIA; BREAST CANCER; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER SIZE; DISTANT METASTASIS; HUMAN; ITALY; MAMMOGRAPHY; NETHERLANDS; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SWITZERLAND; SYSTEMATIC REVIEW; TREND STUDY; UNITED KINGDOM; UNITED STATES;

EID: 79961001783     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq633     Document Type: Review

References (73)

1. Hery C, Ferlay J, Boniol M, Autier P. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol 2008; 19: 1187-1194.
2. Hery C, Ferlay J, Boniol M, Autier P. Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations. Ann Oncol 2008; 19: 1009-1018.
3. Autier P, Boniol M, LaVecchia C et al. Disparities in breast cancer mortality trends between thirty European countries: retrospective trend analysis of WHO mortality database. BMJ 2010; 341: c3620 doi: 10.1136/bmj.c3620.
4. Berry DA, Cronin KA, Plevritis SK et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005; 353: 1784-1792.
5. Tabar L, Fagerberg CJ, Gad A et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985; 1: 829-832.
6. Day NE, Williams DR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989; 59: 954-958.
7. IARC. International Agency for Research on Cancer. Breast Cancer Screening; Handbook. Lyon, France: IARC Press 2002.
8. Fracheboud J, Otto SJ, van Dijck JA et al. Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 2004; 91: 861-867.
9. Smith RA, Duffy SW, Gabe R et al. The randomized trials of breast cancer screening: what have we learned? Radiol Clin N Am 2004; 42: 793-806.
10. Pisani P, Forman D. Declining mortality from breast cancer in Yorkshire, 1983-1998: extent and causes. Br J Cancer 2004; 90: 652-656.
11. Duffy SW, Tabar L, Vitak B et al. The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer 2003; 39: 1755-1760.
12. Autier P, Héry C, Haukka J et al. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol 2009; 27: 5919-5923.
13. Blackman DK, Bennett EM, Miller DS. Trends in self-reported use of mammograms (1989-1997) and papanicolaou tests (1991-1997). MMWR 1999; 48(SS-6): 1-22.
14. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009; 15: 1685-1692.
15. AJCC. American Joint Committee on Cancer: AJCC Cancer Staging Manual, 6th edition. New York, NY: Springer 2002; 171-180.
16. UICC. International Union Against Cancer (UICC), TNM Classification of Malignant Tumours, 6th edition. New York: Wiley-Liss 2002.
17. Shambough E, Gloecker Ries L, Young J et al. SEER Extent of Disease-1988 Instructions. Washington, DC: National Institutes of Health 1992 Codes and Coding.
18. Caplan LS. To screen or not to screen: the issue of breast cancer screening in older women. Public Health Rev 2001; 29: 231-240.
19. Paci E, Duffy S. Overdiagnosis and overtreatment in service screening. Breast Cancer Res 2005; 7: 266-270.
20. Hofvind S, Sorum R, Thoresen S. Incidence tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening program. Acta Oncol 2008; 47: 225-231.
21. Kleinbaum DG, Kupper LL, Muller AL. Applied Regression Analysis and Other Multivariable Methods, 2nd edition. Boston, MA: PWS-Kent 1988.
22. Kricker A, Farac K, Smith D et al. Breast cancer in New South Wales in 1972-1995: tumor size and the impact of mammographic screening. Int J Cancer 1999; 81: 877-880.
23. Verkooijen HM, Fioretta G, Vlastos G et al. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland. Int J Cancer 2003; 104: 778-781.
24. Miller BA, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 1993; 43: 27-41.
25. Garfinkel L, Boring CC, Heath CW Jr. Changing trends. An overview of breast cancer incidence and mortality. Cancer 1994; 74 (1 Suppl): 222-227.
26. Chu KC, Tarone RE, Kessler LG et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996; 88: 1571-1579.
27. Ghafoor A, Jemal A, Ward E et al. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2003; 53: 342-355.
28. Schootman M, Jeffe D, Reschke A, Aft R. The full potential of breast cancer screening use to reduce mortality has not yet been realized in the United States. Breast Cancer Res Treat 2004; 85: 219-222.
29. Hausauer AK, Keegan TH, Chang ET, Clarke CA. Recent breast cancer trends among Asian/Pacific islander, Hispanic, and African-American women in the US: changes by tumor subtype. Breast Cancer Res 2007; 9: R90.
30. Smigal C, Jemal A, Ward E et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 2006; 56: 168-183.
31. Jemal A, Elizabeth Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 2007; 9: R28.
32. Anderson WF, Jatoi I, Devesa SS. Assessing the impact of screening mammography: breast cancer incidence and mortality rates in Connecticut (1943-2002). Breast Cancer Res Treat 2006; 99: 333-340.
33. Polednack AP. Trends in late-stage breast and cervical cancer incidence rates in Connecticut (United States). Cancer Causes Control 2003; 14: 361-365.
34. Barchielli A, Paci E. Trends in breast cancer mortality, incidence, and survival, and mammographic screening in Tuscany, Italy. Cancer Causes Control 2001; 12: 249-255.
35. Paci E, Duffy SW, Giorgi D et al. Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer 2002; 87: 65-69.
36. Hofvind S, Sørum R, Haldorsen T, Langmark F. Incidence of breast cancer before and after implementation of population-based mammography screening. Tidsskr Nor Lægeforen 2006; 126: 2935-2938 (Article in Norwegian).
37. McCann J, Stockton D, Day N. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis. J Med Screen 1998; 5: 42-48.
38. Schouten LJ, de Rijke JM, Schlangen JT, Verbeek AL. Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, The Netherlands. J Med Screen 1998; 5: 37-41.
39. Hiatt RA, Tekawa IS. Mammography utilization in relation to stage at diagnosis for breast cancer: the Kaiser Permanente experience in a large pre-paid health plan. Prog Clin Biol Res 1990; 339: 227-238.
40. Simon MS, Lemanne D, Schwartz AG et al. Recent trends in the incidence of in situ and invasive breast cancer in the Detroit metropolitan area (1975-1988). Cancer 1993; 71: 769-774.
41. Vutuc C, Haidinger G, Waldhoer T. Prevalence of self-reported screening mammography and impact on breast cancer mortality in Austria. Wien Klin Wochenschr 1998; 110(13-14): 485-490.
42. Kotwall C, Covington D, Churchill P et al. Breast conservation surgery for breast cancer at a regional medical center. Am J Surg 1998; 176(6): 510-514.
43. Harvey JM, Sterrett GF, McEvoy S et al. Pathology reporting of breast cancer: trends in 1989-1999, following the introduction of mammographic screening in Western Australia. Pathology 2005; 37(5): 341-346.
44. Jensen AR, Madsen AH, Overgaard J. Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival. Acta Oncol 2008; 47: 537-544.
45. Malmgren JA, Mary K, Atwood MK, Henry G, Kaplan HG. Increase in mammography detected breast cancer over time at a community based regional cancer center: a longitudinal cohort study 1990-2005. BMC Cancer 2008; 8: 131.
46. Taplin SH, Ichikawa L, Buist DSM et al. Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev 2004; 13: 225-234.
47. Glass AG, Lacey JV Jr, Carreon JD, Hoover RN. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 2007; 99: 1152-1161.
48. Prehn A, Clarke C, Topol B et al. Increase in breast cancer incidence in middleaged women during the 1990s. Ann Epidemiol 2002; 12: 476-481.
49. Ward E, Jemal A, Thun M. Regarding "increase in breast cancer incidence in middle-aged women during the 1990s". Ann Epidemiol 2005; 15: 424-425.
50. Louwman WJ, Voogd AC, van Dijck JAMM et al. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control 2007; 19: 97-106.
51. Harmer C, Staples M, Kavanagh AM. Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening? Cancer Causes Control 1999; 10: 333-337.
52. Tasmanian Cancer Registry. Cancer in Tasmania: Incidence and Mortality, 1997-2007 (11 Reports). Hobart, Australia: Menzies Research Institute 2010.
53. NETBCS. National Evaluation Team for Breast Cancer Screening. National evaluation of breast cancer screening in the Netherlands 2005 11th Evaluation report, Rotterdam.
54. Northern Ireland Cancer Registry, Centre for Public Health, School of Medicine, Dentistry & Biomedical Sciences Queen's University Belfast, Belfast. http://www.qub.ac.uk/research-centres/nicr/ (26 August 2010, date last accessed).
55. Scottish Cancer Registry Scottish Cancer Registry, Information Services Division of NHS National Services Scotland (ISD Scotland), Edinburgh. http://showcc.nhsscotland.com/isd//3535.html (26 August 2010, date last accessed).
56. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 17 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2009 Sub (1973-2007 Varying) (www.seer.cancer.gov), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010; based on the November 2009; submission.
57. Connecticut Cancer registry. Connecticut department of Health. http://www.ct.gov/dph/cwp/view.asp?a=3129&q=389716 (26 August 2010, date last accessed).
58. Escobedo LG, Zhong Z, Key C. Breast and cervical cancer screening and disease incidence and stage in New Mexico. Cancer Causes Control 2002; 13: 137-145.
59. Coburn NG, Chung MA, Fulton J, Cady B. Decreased breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-screened population. Cancer Control 2004; 11: 222-230.
60. Fracheboud J, Otto SJ, Holland R et al. Is There a Real Increase of Advanced Breast Cancers in Spite of Mammography Screening?. Geneva, Switzerland: UICC 08 World Cancer Congress, International Union Against Cancer 27-31 2008 (Abstr FC55).
61. Engholm G, Ferlay J, Christensen N et al. NORDCAN: Cancer Incidence, Mortality and Prevalence in the Nordic Countries, Version 3.2. Association of Nordic Cancer Registries. Copenhagen, Denmark: Danish Cancer Society 2008 http://www.ancr.nu;http://www-dep.iarc.fr/nordcan.htm.
62. Ravdin PM, Cronin KA, Howlader N et al. The decrease in breast-cancer incidence in 2003 in the United States. New Eng J Med 2007; 356: 1870-1876.
63. Renard F, Vankrunkelsven P, Van Eycken L et al. Decline in breast cancer incidence in the Flemish region of Belgium after a decline in hormonal replacement therapy. Ann Oncol 2010 May 3 [Epub ahead of print].
64. Daubisse-Marliac L, Delafosse P, Boitard JB et al. Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Ann Oncol 2010 August 2 [Epub ahead of print].
65. Smith-Bindman R, Chu PW, Miglioretti DL. Comparison of screening mammography in the United States and the United Kingdom. JAMA 2003; 290: 2129-2137.
66. Smith-Bindman R, Ballard-Barbash R, Miglioretti DL et al. Comparing the performance of mammography screening in the USA and the UK. J Med Screen 2005; 12: 50-54.
67. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137(5 part 1): 347-360.
68. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
69. Edwards BK, Ward E, Kohler BA et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116: 544-573.
70. Sigurdsson K, Sigvaldason H. Effectiveness of cervical cancer screening in Iceland, 1964-2002: a study on trends in incidence and mortality and the effect of risk factors. Acta Obstet Gynecol Scand 2006; 85: 343-349.
71. Chiu C, Morrell S, Page A et al. Population-based mammography screening and breast cancer incidence in New South Wales, Australia. Cancer Causes Control 2006; 17: 153-160.
72. De Gelder R, van As E, Tilanus-Linthorst MM et al. Breast cancer screening: evidence for false reassurance? Int J Cancer 2008; 123: 680-686.
73. Maaskant AJG, van de Poll-Franse LV, Voogd AC et al. Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat 2009; 113: 173-179.